Steven J. Mento

865 total citations
26 papers, 688 citations indexed

About

Steven J. Mento is a scholar working on Genetics, Molecular Biology and Epidemiology. According to data from OpenAlex, Steven J. Mento has authored 26 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Genetics, 11 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Steven J. Mento's work include Virus-based gene therapy research (10 papers), Animal Virus Infections Studies (5 papers) and CRISPR and Genetic Engineering (5 papers). Steven J. Mento is often cited by papers focused on Virus-based gene therapy research (10 papers), Animal Virus Infections Studies (5 papers) and CRISPR and Genetic Engineering (5 papers). Steven J. Mento collaborates with scholars based in United States, United Kingdom and Switzerland. Steven J. Mento's co-authors include Douglas J. Jolly, David A. Driver, Barbara Belli, Thomas W. Dubensky, John M. Polo, Victor Stollar, Theresa A. Banks, Sunil Chada, S M Chang and Kay Townsend and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Clinical Infectious Diseases and Journal of Virology.

In The Last Decade

Steven J. Mento

26 papers receiving 630 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven J. Mento United States 15 261 257 231 212 177 26 688
Anastassia V. Komarova France 14 236 0.9× 480 1.9× 194 0.8× 180 0.8× 239 1.4× 30 883
Lindsey A. Moser United States 12 413 1.6× 168 0.7× 200 0.9× 226 1.1× 144 0.8× 16 758
M F Saron France 13 220 0.8× 151 0.6× 114 0.5× 136 0.6× 257 1.5× 24 609
Timo Frensing Germany 14 220 0.8× 259 1.0× 146 0.6× 396 1.9× 164 0.9× 19 728
Andrei N. Varnavski Australia 8 395 1.5× 319 1.2× 415 1.8× 96 0.5× 102 0.6× 8 873
Reiko Ohuchi Japan 16 259 1.0× 330 1.3× 145 0.6× 907 4.3× 198 1.1× 25 1.1k
Christina Scheele United States 10 173 0.7× 147 0.6× 198 0.9× 186 0.9× 103 0.6× 13 571
Janet Meredith United Kingdom 16 297 1.1× 516 2.0× 107 0.5× 105 0.5× 164 0.9× 24 1.0k
P. C. Joost Haasnoot Netherlands 11 108 0.4× 486 1.9× 125 0.5× 78 0.4× 97 0.5× 12 733
Karen L. Burke United Kingdom 10 223 0.9× 182 0.7× 91 0.4× 130 0.6× 161 0.9× 14 670

Countries citing papers authored by Steven J. Mento

Since Specialization
Citations

This map shows the geographic impact of Steven J. Mento's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven J. Mento with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven J. Mento more than expected).

Fields of papers citing papers by Steven J. Mento

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven J. Mento. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven J. Mento. The network helps show where Steven J. Mento may publish in the future.

Co-authorship network of co-authors of Steven J. Mento

This figure shows the co-authorship network connecting the top 25 collaborators of Steven J. Mento. A scholar is included among the top collaborators of Steven J. Mento based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven J. Mento. Steven J. Mento is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oladipo, Olusola O., et al.. (2023). An oral caspase inhibitor as monotherapy or with antibiotics eradicates MRSA skin infections in mice. Drug Development Research. 84(8). 1567–1571. 3 indexed citations
2.
Polo, John M., Barbara Belli, David A. Driver, et al.. (1999). Stable alphavirus packaging cell lines for Sindbis virus- and Semliki Forest virus-derived vectors. Proceedings of the National Academy of Sciences. 96(8). 4598–4603. 109 indexed citations
3.
Karavodin, Linda M., Chong Ae Kim, David S. Hsu, et al.. (1998). Generation of a Systemic Antitumor Response with Regional Intratumoral Injections of Interferon γ Retroviral Vector. Human Gene Therapy. 9(15). 2231–2241. 20 indexed citations
4.
Manning, William C., John E. Murphy, Douglas J. Jolly, Steven J. Mento, & Robert Ralston. (1998). Use of a recombinant murine cytomegalovirus expressing vesicular stomatitis virus G protein to pseudotype retroviral vectors. Journal of Virological Methods. 73(1). 31–39. 10 indexed citations
5.
Sällberg, Matti, Janice Hughes, Ali Javadian, et al.. (1998). Genetic Immunization of Chimpanzees Chronically Infected with the Hepatitis B Virus, Using a Recombinant Retroviral Vector Encoding the Hepatitis B Virus Core Antigen. Human Gene Therapy. 9(12). 1719–1729. 48 indexed citations
6.
Martineau, Darlene, WOLFGANG M. KLUMP, James E. McCormack, et al.. (1997). Evaluation of PCR and ELISA Assays for Screening Clinical Trial Subjects for Replication-Competent Retrovirus. Human Gene Therapy. 8(10). 1231–1241. 26 indexed citations
7.
Townsend, Kay, Matti Sällberg, Theresa A. Banks, et al.. (1997). Characterization of CD8+ cytotoxic T-lymphocyte responses after genetic immunization with retrovirus vectors expressing different forms of the hepatitis B virus core and e antigens. Journal of Virology. 71(5). 3365–3374. 46 indexed citations
8.
Warner, John F., et al.. (1995). Retroviral Vectors for HIV Immunotherapy. Annals of the New York Academy of Sciences. 772(1). 105–116. 4 indexed citations
9.
Driver, David A., John M. Polo, Barbara Belli, et al.. (1995). Layered Amplification of Gene Expression with a DNA Gene Delivery System. Annals of the New York Academy of Sciences. 772(1). 261–264. 19 indexed citations
10.
Sajjadi, Nancy, et al.. (1994). Recombinant Retroviral Vector Delivered Intramuscularly Localizes to the Site of Injection in Mice. Human Gene Therapy. 5(6). 693–699. 11 indexed citations
11.
Mishkin, Eric M., John V. Fahey, Yoichiro Kino, et al.. (1991). Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models. Vaccine. 9(3). 147–153. 29 indexed citations
12.
Weeks-Levy, Carolyn, et al.. (1991). Identification and characterization of a new base substitution in the vaccine strain of sabin 3 poliovirus. Virology. 185(2). 934–937. 30 indexed citations
13.
Tatem, Joanne M., et al.. (1991). Oral poliovirus vaccine in the United States: Molecular characterization of sabin type 3 after replication in the gut of vaccinees. Journal of Medical Virology. 35(2). 101–109. 16 indexed citations
14.
Mento, Steven J., et al.. (1988). Characterization of Vero cells. Journal of Biological Standardization. 16(4). 311–320. 15 indexed citations
15.
Rayfield, Emily J. & Steven J. Mento. (1983). Viruses May Be Etiologic Agents for Non-Insulin-Dependent (Type II) Diabetes. Clinical Infectious Diseases. 5(2). 341–345. 7 indexed citations
16.
Mento, Steven J., et al.. (1979). ?-Amanitin resistant RNA polymerase II from cell mutants resistant to ?-amanitin. Cell Biology International Reports. 3(9). 725–732. 2 indexed citations
17.
Mento, Steven J., Frank Malinoski, & Victor Stollar. (1979). Phenotypic characterization of ouabain‐resistant Aedes albopictus cells. Journal of Cellular Physiology. 101(3). 515–521. 3 indexed citations
18.
Mento, Steven J. & Victor Stollar. (1978). Isolation and partial characterization of drug-resistantAedes albopictus cells. Somatic Cell and Molecular Genetics. 4(2). 179–191. 23 indexed citations
19.
Mento, Steven J. & Victor Stollar. (1978). Effect of ouabain on Sindbis virus replication in ouabain-sensitive and ouabain-resistant Aedes albopictus cells (Singh). Virology. 87(1). 58–65. 15 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Anastassia V. Komarova Breakdown of academic impact, for papers by Lindsey A. Moser Breakdown of academic impact, for papers by M F Saron Breakdown of academic impact, for papers by Timo Frensing Breakdown of academic impact, for papers by Andrei N. Varnavski Breakdown of academic impact, for papers by Reiko Ohuchi Breakdown of academic impact, for papers by Christina Scheele Breakdown of academic impact, for papers by Janet Meredith Breakdown of academic impact, for papers by P. C. Joost Haasnoot Breakdown of academic impact, for papers by Karen L. Burke
Rankless by CCL
2026